GlassScriptPhysician profile
Bethany Roderer
NPI 1730458571
$2,131.64
in general payments reported to CMS, 2019-2025
41 companies · $43.32 in 2025
The $43.32 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,013 · 2022: $75.08 · 2025: $43.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $267.31 | 2021-2022 | |
| Janssen Biotech, INC. | $193.40 | 2021-2022 | |
| Incyte Corporation | $166.96 | 2021 | |
| Astellas Pharma US INC | $142.56 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $92.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.59 | 2021 | |
| Lilly USA, LLC | $73.04 | 2021 | |
| Merck Sharp & Dohme LLC | $71.06 | 2021 | |
| Genzyme Corporation | $65.11 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.07 | 2021-2022 | |
| Seagen INC. | $59.91 | 2021 | |
| Rigel Pharmaceuticals, INC. | $58.03 | 2021 | |
| Taiho Oncology, INC. | $57.76 | 2021 | |
| Glaxosmithkline, LLC. | $52.80 | 2021 | |
| Eisai INC. | $50.37 | 2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Roderer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.